Market Cap: $6.51B
LI
Lantheus Holdings, Inc.
LNTH
NASDAQ (NASDAQ Global Market)USD
Market Cap: $6.51B
Lantheus Holdings (Ticker: LNTH) faces a significant challenge in its quest for FDA approval of LNTH-2501, a PET diagnostic imaging kit aimed at somatostatin receptor-positive neuroendocrine tumors. R…
Lantheus Holdings (Ticker: LNTH) makes significant strides in the diagnostic imaging industry, with its investigational PET/CT agent, LNTH-2513 (18F-GP1), recently honored with the Image of the Year a…
Lantheus Holdings achieves significant milestone with its investigational PET imaging agent LNTH-2513 (18F-GP1), awarded SNMMI’s prestigious 2026 “Image of the Year.” The accolade highlights clinical…
Lantheus Holdings (Ticker: LNTH) recently celebrates a major achievement with its investigational PET imaging agent LNTH-2513 (18F-GP1) being awarded the SNMMI’s prestigious 2026 “Image of the Year.”…
Lantheus Holdings (Ticker: LNTH) makes strides in the field of medical imaging with its investigational PET/CT imaging agent LNTH-2513 (18F-GP1), recently honored with the SNMMI’s Image of the Year aw…
Lantheus Holdings (Ticker: LNTH) has recently received notable acclaim in the realm of diagnostic imaging with its investigational product, LNTH-2513 (18F-GP1) PET/CT, which has been awarded SNMMI’s 2…
Lantheus Holdings (Ticker: LNTH) is preparing to present critical clinical and real-world data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, marking a significant…
Lantheus Holdings (Ticker: LNTH) is set to present crucial clinical findings for its radiopharmaceutical product LNTH-2403 at the 2026 ASCO Annual Meeting, an event that may significantly influence it…
Lantheus Holdings Poised for Innovation as Industry Rivals Report Strong Earnings Lantheus Holdings, a leader in diagnostic imaging and radiopharmaceuticals, remains focused on the development and com…
Lantheus Holdings: Enhancing Diagnostic Imaging through Innovative Solutions Lantheus Holdings, a leader in the field of diagnostic imaging, remains at the forefront of developing advanced radiopharma…
### Lantheus Holdings Focuses on Innovation in Diagnostic Imaging Lantheus Holdings positions itself at the forefront of the medical imaging sector by emphasizing innovation and specialized solutions…
Lantheus Holdings Faces Class Action Lawsuit Over Misleading Projections Lantheus Holdings, Inc. finds itself in the spotlight as The Gross Law Firm announces a notice to shareholders regarding a pote…
Lantheus Holdings Faces Class Action Lawsuit Over Pylarify Sales Projections Lantheus Holdings, Inc., a prominent player in the medical imaging sector, finds itself under scrutiny as The Gross Law Fir…
Class Action Lawsuits Spotlight Lantheus Holdings’ Alleged Misconduct Lantheus Holdings, Inc. faces significant scrutiny as multiple law firms announce class action lawsuits alleging violations of the…
Lantheus Holdings Faces Class Action Lawsuit Over Alleged Misrepresentation Lantheus Holdings, Inc. confronts a securities fraud class action lawsuit initiated by the Law Offices of Frank R. Cruz, tar…
Lantheus Holdings: A Critical Earnings Announcement Ahead Lantheus Holdings is poised to unveil its quarterly earnings on November 6, 2025, a date that has garnered considerable attention from investo…
Lantheus Holdings Faces Securities Fraud Class Action Over Pylarify Misrepresentation Lantheus Holdings, Inc. (NASDAQ: LNTH) is currently embroiled in a significant legal challenge as a class action l…
Lantheus Holdings Faces Class Action Lawsuits Over Pylarify Misrepresentations Lantheus Holdings, Inc. is currently embroiled in multiple class action lawsuits alleging serious violations of the Secur…
Lantheus Holdings Faces Class Action Lawsuits Over Pylarify Misrepresentation Lantheus Holdings, Inc. is currently embroiled in a series of class action lawsuits stemming from allegations of misleadin…
Lantheus Holdings Faces Class Action Lawsuit Over Alleged Securities Fraud Lantheus Holdings, Inc. is currently embroiled in a class action securities lawsuit initiated by Levi & Korsinsky, LLP, as in…
Lantheus Holdings Faces Class Action Over Drug Pricing Concerns Lantheus Holdings, Inc. finds itself at the center of a class action lawsuit concerning its drug Pylarify, as Rosen Law Firm notifies in…
Lantheus Holdings Faces Class Action Lawsuits over Misleading Statements on Pylarify Lantheus Holdings, Inc. is currently embroiled in multiple class action lawsuits stemming from allegations that the…
Lantheus Holdings Faces Class Action Over Pylarify Market Statements Lantheus Holdings, Inc. is currently embroiled in a class action lawsuit initiated by the DJS Law Group, highlighting serious alleg…
Lantheus Holdings Faces Class Action Lawsuits Over Alleged Misleading Statements Lantheus Holdings, Inc. is currently embroiled in legal challenges as two law firms, Rosen Law Firm and DJS Law Group,…
Lantheus Holdings Faces Class Action Lawsuits Over Misleading Statements Regarding Pylarify Lantheus Holdings, Inc. is currently embroiled in legal challenges as multiple law firms announce class acti…